HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial

Early initiation of antiretroviral therapy (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 participants in the HPTN 052 trial who started ART at CD4 counts of 350–...

詳細記述

保存先:
書誌詳細
出版年:J Acquir Immune Defic Syndr
主要な著者: Fogel, Jessica M., Hudelson, Sarah E., Ou, San-San, Hart, Stephen, Wallis, Carole, Morgado, Mariza G., Saravanan, Shanmugam, Tripathy, Srikanth, Hovind, Laura, Piwowar-Manning, Estelle, Sabin, Devin, McCauley, Marybeth, Gamble, Theresa, Zhang, Xinyi Cindy, Eron, Joseph J., Gallant, Joel E., Kumwenda, Johnstone, Makhema, Joseph, Kumarasamy, Nagalingeswaran, Chariyalertsak, Suwat, Hakim, James, Badal-Faesen, Sharlaa, Akelo, Victor, Hosseinipour, Mina C., Santos, Breno Riegel, Godbole, Sheela V., Pilotto, Jose Henrique, Grinsztejn, Beatriz, Panchia, Ravindre, Mayer, Kenneth H., Chen, Ying Q., Cohen, Myron S., Eshleman, Susan H.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911290/
https://ncbi.nlm.nih.gov/pubmed/26859828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000951
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料